This article is in the news archive.
Initial positive results indicate that new gene therapy could revolutionise treatment for Parkinson’s disease
A story has appeared on Sky News on April 12th on Oxford BioMedica’s innovative gene-based treatment for Parkinson’s disease. The programme, which was broadcast ahead of Parkinson’s Awareness Week starting on 16 April, includes interviews with Sheila Roy, a patient who has been treated with ProSavin®, Dr Philip Buttery, a clinician at Addenbrooke’s Hospital, and Stuart Naylor, Chief Scientific Officer at Oxford BioMedica.
Posted on 13/04/2012
Go to the news index page.